Indian Immunologicals Profile
Key Indicators
- Authorised Capital ₹ 400.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 54.00 Cr
as on 11-12-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 335.16 Cr
as on 11-12-2024
- Satisfied Charges ₹ 887.42 Cr
as on 11-12-2024
- Revenue 9.74%
(FY 2022)
- Profit 239.81%
(FY 2022)
- Ebitda 164.63%
(FY 2022)
- Net Worth 25.26%
(FY 2022)
- Total Assets 8.79%
(FY 2022)
About Indian Immunologicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 400.00 Cr and a paid-up capital of Rs 54.00 Cr.
The company currently has active open charges totaling ₹335.16 Cr. The company has closed loans amounting to ₹887.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indian Immunologicals Limited India are Appalaraja Ganasala as CFO and Shuchi Sharma as Company Secretary. Agnihotra Chavali, Kinnera Bhagavatula, Meeneshkumar Shah, and Five other members serve as directors at the Company.
- CIN/LLPIN
U72200TG1999PLC032666
- Company No.
032666
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Oct 1999
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Indian Immunologicals Limited offer?
Indian Immunologicals Limited offers a wide range of products and services, including Animal Medicines & Health Care, Animal Treatment Services, Medical Consultants & Clinics, Health Care Service, Pet Care, Pet Grooming, Popular Category, Stomach Care.
Who are the key members and board of directors at Indian Immunologicals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Kanakasapapathy  | Managing Director | 01-Nov-2013 | Current |
Appalaraja Ganasala  | CFO | 01-Jul-2017 | Current |
| Shuchi Sharma | Company Secretary | 10-Jul-2017 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Mehendale | Director | 12-Mar-2018 | Current |
| Kinnera Bhagavatula | Director | 18-Mar-2015 | Current |
| Agnihotra Chavali | Director | 18-Mar-2015 | Current |
| Meeneshkumar Shah | Director | 15-Jul-2021 | Current |
| Devanand Pathayapura | Director | 12-Nov-2021 | Current |
| Priyabrata Pattnaik | Whole-Time Director | 16-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Indian Immunologicals.
Indian Immunologicals Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.74% increase. The company also saw a substantial improvement in profitability, with a 239.81% increase in profit. The company's net worth Soared by an impressive increase of 25.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Immunologicals?
In 2023, Indian Immunologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nddb Dairy ServicesActive 15 years 2 monthsMeeneshkumar Shah and Devanand Pathayapura are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 May 2016 | ₹5.00 Cr | Open |
Others Creation Date: 18 Mar 2016 | ₹85.16 Cr | Open |
Others Creation Date: 12 Dec 2013 | ₹40.00 Cr | Open |
How Many Employees Work at Indian Immunologicals?
Unlock and access historical data on people associated with Indian Immunologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Immunologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Immunologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
